[{"from": "human", "value": "Could you provide a description of this molecule? [C][N][Branch1][C][C][C][C][N][Branch1][C][C][C][=C][C][=Branch2][Ring2][=C][=C][Branch1][N][C][=C][Ring1][=Branch1][N][C][=Branch1][C][=O][C][=C][N][C][=N][C][=C][C][=Branch1][Ring2][=N][Ring1][=Branch1][C][=C][N][Branch1][O][C][=C][C][=C][C][=C][Ring1][=Branch1][Ring1][=Branch2][C][C][C][Ring1][Ring1][O][C]"}, {"from": "gpt", "value": "The molecule is an orally available inhibitor of the epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic activity. Upon administration, aumolertinib binds to and inhibits EGFR T790M, a secondarily acquired resistance mutation, inhibits the tyrosine kinase activity of EGFR T790M, prevents EGFR T790M-mediated signaling and leads to cell death in EGFR T790M-expressing tumor cells. EGFR, a receptor tyrosine kinase that is mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization."}]